These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14613685)

  • 21. Crystallized verbal skills in schizophrenia: relationship to neurocognition, symptoms, and functional status.
    Kurtz MM; Donato J; Rose J
    Neuropsychology; 2011 Nov; 25(6):784-791. PubMed ID: 21928906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into neurocognitive dysfunction in schizophrenia.
    Medalia A; Thysen J
    Schizophr Bull; 2008 Nov; 34(6):1221-30. PubMed ID: 18199632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily activities, cognition and community functioning in persons with schizophrenia.
    Aubin G; Stip E; Gélinas I; Rainville C; Chapparo C
    Schizophr Res; 2009 Feb; 107(2-3):313-8. PubMed ID: 18824328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological functioning in first-episode psychosis--evidence of specific deficits.
    Riley EM; McGovern D; Mockler D; Doku VC; OCeallaigh S; Fannon DG; Tennakoon L; Santamaria M; Soni W; Morris RG; Sharma T
    Schizophr Res; 2000 May; 43(1):47-55. PubMed ID: 10828414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing a minimal executive operation in schizophrenia.
    Grillon ML; Johnson MK; Danion JM; Rizzo L; Verdet C; Huron C
    Psychiatry Res; 2005 Nov; 137(1-2):37-48. PubMed ID: 16226315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Verbal memory in schizophrenia: additional evidence of subtypes having different cognitive deficits.
    Bruder GE; Wexler BE; Sage MM; Gil RB; Gorman JM
    Schizophr Res; 2004 Jun; 68(2-3):137-47. PubMed ID: 15099598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment of executive function as a core symptom of schizophrenia.
    Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological profile in adult schizophrenia measured with the CMINDS.
    van Erp TG; Preda A; Turner JA; Callahan S; Calhoun VD; Bustillo JR; Lim KO; Mueller B; Brown GG; Vaidya JG; McEwen S; Belger A; Voyvodic J; Mathalon DH; Nguyen D; Ford JM; Potkin SG;
    Psychiatry Res; 2015 Dec; 230(3):826-34. PubMed ID: 26586142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological differences among empirically derived clinical subtypes of schizophrenia.
    Hill SK; Ragland JD; Gur RC; Gur RE
    Neuropsychology; 2001 Oct; 15(4):492-501. PubMed ID: 11761038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognition in acute and chronic depression: personality disorder, major depression, and schizophrenia.
    Burgess JW
    Biol Psychiatry; 1991 Aug; 30(3):305-9. PubMed ID: 1912119
    [No Abstract]   [Full Text] [Related]  

  • 33. Cognitive inhibition and schizophrenic symptom subgroups.
    Williams LM
    Schizophr Bull; 1996; 22(1):139-51. PubMed ID: 8685656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecological assessment of executive dysfunction in the psychosis prodrome: a pilot study.
    Niendam TA; Horwitz J; Bearden CE; Cannon TD
    Schizophr Res; 2007 Jul; 93(1-3):350-4. PubMed ID: 17467957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker.
    Pflueger MO; Gschwandtner U; Stieglitz RD; Riecher-Rössler A
    Schizophr Res; 2007 Dec; 97(1-3):14-24. PubMed ID: 17936587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia.
    Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Goldman MB
    Neuropsychology; 2009 May; 23(3):307-14. PubMed ID: 19413445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
    Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
    J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social and cognitive functioning in psychosis.
    Addington J; Addington D
    Schizophr Res; 2008 Feb; 99(1-3):176-81. PubMed ID: 17681756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.